The University of New Mexico Hospital entered into a three‑year sole‑source contract to purchase Tristel OPH, a high‑level disinfectant foam designed exclusively for ophthalmic instruments. The product is FDA‑cleared, offers a rapid two‑minute contact time, and reduces PPE requirements while protecting instruments from corrosion. The contract value is $60,000, with the vendor Advancing Eyecare providing the product from its Jacksonville, FL location. The procurement was justified on the basis of unique expertise and the absence of any comparable alternatives after an extensive web search.
• Product: Tristel OPH foam (high‑level disinfectant for reusable ophthalmic devices)
• Vendor: Advancing Eyecare (Jacksonville, FL) – sole source, $60 K total for 3 years
• Reason for sole‑source: Proprietary, FDA‑cleared formulation with no identified competitors
• Contract period: 05/19/2026 – 05/19/2029, with optional renewals
• Funding: State of New Mexico (UNMH) budget, posted for 30 days per NM law